Antengene: Gunning To Move Up in Line
This Insight provides an in-depth review of pre-revenue biotechnology Antegene that plans to list on the HKEX. We discuss the pipeline, market...
579 Views
China Healthcare Weekly (Oct.30)
This article summarized major industry viewpoints, companies news and capital market review in healthcare industry in China during the week of Oct.30.
457 Views
What HKEX Biotech "Step-Ups" Can Tell Us
This Insight explains the concept of valuation "step-ups" for pre-revenue biotechnology companies listing on the HKEX and how to use this data to...
507 Views
HSCI and Stock Connect - Biotech Stocks Now Eligible; Inclusion & Exclusion Possibilities
Hang Seng Indexes Company (HSIL) reviews the constituents of the Hang Seng Composite Index (HSCI) on a half yearly basis in March and September...
992 Views
Burning Rock Biotech IPO Initiation: Burning Ambitions
Burning Rock Biotech (BNR US) is a precision oncology and early cancer detection company. It is China’s number one NGS-based cancer therapy...
370 Views